SDGR
Schrodinger, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$27.56
+1.40%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$27.20
From 52W high−15.46%
Volume525750.00
Market cap$2.06B
P/E (TTM)—
P/S (TTM)8.0x
Div yield—
Key dataNov 4, 2026
Open
$27.20
From 52W high
−15.46%
Volume
525750.00
Market cap
$2.06B
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−38.1x
P/E (TTM)
—
RSI (14)
51.9
MomentumView details →
1D Return
+1.40%
YTD Return
+50.06%
SummaryUpdated Jun 1, 2026
Schrödinger, Inc. (NASDAQ:SDGR) is a computational platform company founded in 1990 and headquartered in New York, New York. The company went public in February 2020 and operates at the intersection of physics-based computational methods and drug discovery. Schrödinger has evolved from a software company serving the pharmaceutical industry into a dual-business model enterprise that both licenses its computational platform to external customers and develops its own proprietary drug candidates. The company serves biopharmaceutical companies, industrial firms, academic institutions, and government laboratories worldwide.
Similar companies
Latest newsMore news →
Schrödinger granted restricted stock units covering 5,716 common shares to five newly hired employees as inducement awards under its 2021 Inducement Equity Incentive Plan.9d agoSchrödinger announced publication in Nature Co., Ltd. of joint research with The Trustees of Columbia University in The City of New York and the New York Structural Biology Center on the atomic-scale structure of lithium-ion battery electrolytes.21d agoSchrödinger, Inc. granted restricted stock units covering 2,243 shares of its common stock to three newly hired employees on September 13, 2026, under its 2021 Inducement Equity Incentive Plan.48d ago